Milestone Scientific Net Income
| MLSS Stock | USD 0.27 0.01 4.54% |
As of the 9th of February, Milestone Scientific secures the Risk Adjusted Performance of (0.1), mean deviation of 3.51, and Standard Deviation of 4.7. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Milestone Scientific, as well as the relationship between them. Please verify Milestone Scientific variance and skewness to decide if Milestone Scientific is priced some-what accurately, providing market reflects its recent price of 0.27180001 per share. As Milestone Scientific appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
Milestone Scientific Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.2876 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.2 M | -4.5 M | |
| Net Loss | -4.2 M | -4.5 M | |
| Net Loss | -6.1 M | -6.4 M | |
| Net Loss | (0.05) | (0.06) | |
| Net Income Per E B T | 1.14 | 1.18 |
Milestone | Net Income | Build AI portfolio with Milestone Stock |
The evolution of Net Income for Milestone Scientific provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Milestone Scientific compares to historical norms and industry peers.
Latest Milestone Scientific's Net Income Growth Pattern
Below is the plot of the Net Income of Milestone Scientific over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Milestone Scientific financial statement analysis. It represents the amount of money remaining after all of Milestone Scientific operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Milestone Scientific's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Scientific's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (4.71 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Milestone Net Income Regression Statistics
| Arithmetic Mean | (4,661,608) | |
| Geometric Mean | 3,975,703 | |
| Coefficient Of Variation | (61.24) | |
| Mean Deviation | 2,287,667 | |
| Median | (5,186,793) | |
| Standard Deviation | 2,854,601 | |
| Sample Variance | 8.1T | |
| Range | 10.2M | |
| R-Value | (0.62) | |
| Mean Square Error | 5.4T | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | (347,974) | |
| Total Sum of Squares | 130.4T |
Milestone Net Income History
Other Fundumenentals of Milestone Scientific
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Milestone Scientific Net Income component correlations
Milestone Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Milestone Scientific is extremely important. It helps to project a fair market value of Milestone Stock properly, considering its historical fundamentals such as Net Income. Since Milestone Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Milestone Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Milestone Scientific's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Milestone introduce new products? Factors like these will boost the valuation of Milestone Scientific. Expected growth trajectory for Milestone significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Milestone Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
Investors evaluate Milestone Scientific using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Milestone Scientific's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Milestone Scientific's market price to deviate significantly from intrinsic value.
Understanding that Milestone Scientific's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Milestone Scientific represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Milestone Scientific's market price signifies the transaction level at which participants voluntarily complete trades.
Milestone Scientific 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Milestone Scientific's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Milestone Scientific.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Milestone Scientific on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Milestone Scientific or generate 0.0% return on investment in Milestone Scientific over 90 days. Milestone Scientific is related to or competes with Precision Optics, India Globalization, Nexgel, Myomo, Retractable Technologies, MIRA Pharmaceuticals, and Apimeds Pharmaceuticals. Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and d... More
Milestone Scientific Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Milestone Scientific's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Milestone Scientific upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 23.59 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 7.41 |
Milestone Scientific Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Milestone Scientific's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Milestone Scientific's standard deviation. In reality, there are many statistical measures that can use Milestone Scientific historical prices to predict the future Milestone Scientific's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (1.57) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Scientific's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Scientific February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (1.56) | |||
| Mean Deviation | 3.51 | |||
| Coefficient Of Variation | (764.99) | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.11 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (1.57) | |||
| Maximum Drawdown | 23.59 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 7.41 | |||
| Skewness | 0.1526 | |||
| Kurtosis | 0.7832 |
Milestone Scientific Backtested Returns
Milestone Scientific has Sharpe Ratio of -0.1, which conveys that the firm had a -0.1 % return per unit of risk over the last 3 months. Milestone Scientific exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Milestone Scientific's Standard Deviation of 4.7, mean deviation of 3.51, and Risk Adjusted Performance of (0.1) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Milestone Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Milestone Scientific is expected to be smaller as well. At this point, Milestone Scientific has a negative expected return of -0.47%. Please make sure to verify Milestone Scientific's information ratio, skewness, as well as the relationship between the Skewness and day typical price , to decide if Milestone Scientific performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Milestone Scientific has virtually no predictability. Overlapping area represents the amount of predictability between Milestone Scientific time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Milestone Scientific price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Milestone Scientific price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Milestone Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Milestone Scientific reported net income of (4.71 Million). This is 101.38% lower than that of the Health Care Equipment & Supplies sector and 104.73% lower than that of the Health Care industry. The net income for all United States stocks is 100.83% higher than that of the company.
Milestone Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Milestone Scientific's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Milestone Scientific could also be used in its relative valuation, which is a method of valuing Milestone Scientific by comparing valuation metrics of similar companies.Milestone Scientific is currently under evaluation in net income category among its peers.
Milestone Scientific Current Valuation Drivers
We derive many important indicators used in calculating different scores of Milestone Scientific from analyzing Milestone Scientific's financial statements. These drivers represent accounts that assess Milestone Scientific's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Milestone Scientific's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 141.8M | 33.9M | 50.2M | 76.6M | 88.1M | 124.1M | |
| Enterprise Value | 127.6M | 25.7M | 47.6M | 73.7M | 84.7M | 121.5M |
Milestone Fundamentals
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.42 | ||||
| Profit Margin | (0.75) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 20.43 M | ||||
| Shares Outstanding | 78.63 M | ||||
| Shares Owned By Insiders | 22.60 % | ||||
| Shares Owned By Institutions | 5.00 % | ||||
| Number Of Shares Shorted | 393 K | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 8.13 X | ||||
| Price To Sales | 2.32 X | ||||
| Revenue | 8.63 M | ||||
| Gross Profit | 6.42 M | ||||
| EBITDA | (6.72 M) | ||||
| Net Income | (4.71 M) | ||||
| Cash And Equivalents | 9.81 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 349.05 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.95 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | (2.92 M) | ||||
| Short Ratio | 0.80 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 17 | ||||
| Beta | 0.91 | ||||
| Market Capitalization | 20.72 M | ||||
| Total Asset | 9.8 M | ||||
| Retained Earnings | (128.05 M) | ||||
| Working Capital | 5.54 M | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 4.4 M | ||||
| Net Asset | 9.8 M |
About Milestone Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Milestone Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.